Back to Knowledge Center
General Medicine ICD-10: N10

Emphysematous Pyelonephritis

A life-threatening, gas-producing bacterial infection of the kidney, almost exclusively seen in diabetics with poor blood sugar control.

Source: WHO / CDC / NIH Evidence Guidelines
Updated: Aug 12, 2026
3,067 Views
Red Flag Warning & Emergency Situations

Emergency Management: Septic shock with Disseminated Intravascular Coagulation (DIC). Requires immediate ICU transfer, vasopressors (Norepinephrine), blood products, and emergent surgical intervention.

Core Definition:

Emphysematous Pyelonephritis (EPN) is a rare, severe, acute necrotizing infection of the renal parenchyma and perirenal tissue caused by gas-forming uropathogens. It is characterized by the presence of gas within the kidney, collecting system, or surrounding tissues.

Detailed Overview

EPN is a urologic emergency that predominantly affects poorly controlled diabetic patients. The gas is a result of the fermentation of necrotic tissue and glucose by coliform bacteria. It carries a high mortality rate (up to 50% historically, though lower with modern interventions) due to overwhelming sepsis and multi-organ failure. Management ranges from aggressive medical therapy with percutaneous drainage to emergent nephrectomy.

Epidemiology & Demographics

Very rare. Women are affected much more frequently than men (ratio up to 6:1), largely paralleling the higher incidence of UTIs in women. The median age is roughly 60 years. Over 90% of cases occur in patients with Diabetes Mellitus.

Etiological Mechanism

Infection primarily by Escherichia coli (up to 70% of cases), followed by Klebsiella pneumoniae, Proteus mirabilis, and rarely Pseudomonas or Candida species.

Primary Causes

Bacterial fermentation of glucose in the setting of hyperglycemia, tissue ischemia, and impaired host immunity.

Three critical factors contribute to EPN: high tissue glucose concentrations, impaired tissue perfusion (diabetic microangiopathy or obstruction), and the presence of gas-forming organisms. The bacteria utilize mixed-acid fermentation to metabolize the abundant glucose, producing carbon dioxide and hydrogen gas. The gas accumulates in the necrotic renal parenchyma and perirenal spaces, exacerbating ischemia by compressing local blood vessels, leading to massive renal infarction, profound septic shock, and toxemia.

Diagnostic Criteria & Guidelines

Diagnosis is definitively established by a non-contrast Computed Tomography (CT) scan of the abdomen and pelvis demonstrating gas within the renal parenchyma or surrounding spaces. Abdominal X-ray may show a mottled gas pattern over the renal fossa, but CT is essential for staging and planning.

First-Line Treatment:

Immediate resuscitation: IV fluids, glycemic control (insulin drip), and broad-spectrum IV antibiotics (e.g., Piperacillin-Tazobactam 4.5g IV q6h or Meropenem 1g IV q8h). Source control is paramount: Image-guided Percutaneous Catheter Drainage (PCD) to evacuate pus and gas, alongside relief of any urinary obstruction (e.g., Double-J ureteral stent).

Second-Line & Adjunctive Therapy

For patients with extensive parenchymal destruction (Class 3/4), two or more risk factors (thrombocytopenia, AKI, altered mentation), or failure to improve clinically within 48-72 hours of percutaneous drainage: Emergent Simple Nephrectomy. Nephrectomy removes the nidus of infection but carries high surgical risk in critically ill patients.

Surgical & Procedural Management

Simple or radical nephrectomy. Open surgical approach is usually required due to severe inflammatory adhesions and the critical state of the patient.

Patient Counseling & Advice

If the patient survives and keeps the kidney, emphasize that absolute control of their diabetes is a matter of life and death to prevent a recurrence. Discuss the possibility of long-term renal impairment.

Follow-Up & Monitoring Schedule

Serial CT scans every 1-2 weeks post-drainage to ensure resolution of gas and collections. Close monitoring of renal function and blood glucose.

Preventive Strategies

Prompt, aggressive treatment of simple UTIs in diabetic patients. Meticulous glycemic control.

Historically, mortality was nearly 50-80% with medical management alone. With early CT diagnosis and combined medical/percutaneous drainage, mortality has dropped to around 15-20%.

Authoritative Sources & Evidence References
World Health Organization (WHO) & CDC Guidelines: Information compiled from current international clinical practice guidelines.

System Notice

Confirm Action